RecruitingNCT06326684
Suvorexant or placebo in a study of alcohol-related motivation and behavior
About this title
Read the official source — NCT06326684Medication studyAges 21–55United StatesAddiction
Understand this study
Who could participate?
Listed age limits: 21 years to 55 years.
- Listed locations
- LexingtonSee all locations and recruitment
- Study phase
- Early phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: June 7, 2024
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 30
- Sponsor
- William Stoops
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Early Phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
- Locations
- United States
- Age range
- From 21 Years to 55 Years
- Official registry ID
- NCT06326684
- Official title
Show the full official title
Influence of Orexin Antagonism on Motivation for Alcohol
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Lexington
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is William Stoops.
Does this study involve medication?
Yes. The study involves medication, including Alcohol, Placebo and Suvorexant.
Who can participate?
Listed age limits: 21 years to 55 years.
Is this study still recruiting?
The registry lists this study as recruiting.
